Skip to content

Evolus EOLS Business Segments — Total net revenues

Similar metrics at other companies

Arcutis Biotherapeutics, Inc. logo
ARQTReportable Segment — Total revenues
$105.4M+60.1%
loanDepot logo
LDIReportable Segment — Total net revenues
$286.4M
BioCryst Pharmaceuticals logo
BCRXReportable Segment — Total revenues
$156.41M+7.5%
Open Text logo
OTEXReportable Segment — Total revenues
$1.28B+2.2%
Tarsus Pharmaceuticals, Inc. logo
TARSReportable Segment — Total revenues
$162.05M+107%
RingCentral logo
RNGReportable Segment — Total revenues
$644.2M+5.3%

Other financials

Income statement

See full
Revenue$73.1M+6.7%
Gross profit$48.9M+4.8%
Operating income-$6.8M+54.9%
Net income-$10.7M+43.5%
EPS (diluted)-$0.16+46.7%

Balance sheet

See full
Cash & equivalents$49.8M-26.7%
Total debt$164.9M-4.1%
Total equity-$28.8M-336%
Total assets$220.6M+3.4%

Cash flow

See full
Operating cash flow-$10.0M+36.3%
CapEx$415.0K+30.1%
Free cash flow-$10.4M+35.0%

Valuation

See full
Market cap$470.86M-21.3%
Enterprise value$585.97M-16.6%
P/S1.6×-0.6×

Profitability

See full
Gross margin66.1%-2.4pp
Operating margin-13.7%-1.9pp
Net margin-14.4%-3.3pp
FCF margin-9.6%-3.6pp

Returns & leverage

See full
Return on equity-472.6%-1,534pp
Debt / equity22.2×
Current ratio-0.3×

Where this comes from

Reported directly by Evolus in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Evolus’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolus's business segments — total net revenues.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evolus's business segments — total net revenues?
Evolus (EOLS) reported business segments — total net revenues of $73.14M in Q1 2026.
How has Evolus's business segments — total net revenues changed year-over-year?
Evolus's business segments — total net revenues increased by 6.7% year-over-year, from $68.52M to $73.14M.
What is the long-term trend for Evolus's business segments — total net revenues?
Over 3 years (2022 to 2025), Evolus's business segments — total net revenues has grown at a 26.0% compound annual growth rate (CAGR), from $148.62M to $297.18M.
What does business segments — total net revenues mean?
Represents the total gross revenue generated by the reportable business segment after accounting for returns, allowances, and discounts. This metric serves as the primary indicator of the segment's market demand and commercial scale within the aesthetic beauty industry.